lacosamide accord
accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide ucb
ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptics, - lacosamide ucb er indisert som monoterapi og tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.
lacosamide adroiq
extrovis eu ltd. - lakosamid - epilepsi - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide medical valley 100 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 100 mg
lacosamide medical valley 50 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 50 mg
lacosamide medical valley 150 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 150 mg
lacosamide medical valley 200 mg
medical valley invest ab - lakosamid - tablett, filmdrasjert - 200 mg
vimpat
ucb pharma sa - lakosamid - epilepsi - antiepileptics, - vimpat er indisert som monoterapi og tilleggsbehandling ved behandling av partielle anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.
furosemide kalceks 10 mg/ ml
as kalceks - furosemid - injeksjons-/infusjonsvæske, oppløsning - 10 mg/ ml
furosemide baxter 10 mg/ ml
baxter holding b.v. - furosemid - injeksjonsvæske, oppløsning - 10 mg/ ml